EUVIMEDObjevte EUVIMED
Systematische ÜbersichtMetaanalyseOpen access

Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis

Ziqi Jiang, Yuan Xu, Shuyu Jia, Hongsheng Liu

Journal of Medical Internet Research · 2026-08-13 · 28 · e93892-e93892

DOI: 10.2196/93892 ↗

At a glance

Systematische Übersicht in Journal of Medical Internet Research, published online on 2026-08-13. Written by Ziqi Jiang and 3 co-authors. Institution: Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No.1 Shuaifuyuan, Wangfujing, Beijing, Don…. Major MEDLINE topics: Carcinoma, Non-Small-Cell Lung, Radiomics, Lung Neoplasms, Neoadjuvant Therapy. Cited 3 times so far (Crossref); 50 references. The full text is freely available in PubMed Central.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Non–small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality worldwide. Accurate early prediction of response to neoadjuvant therapy is critical.

Objective

We aimed to evaluate the diagnostic performance of radiomics-based AI in predicting pathological complete response (pCR) and major pathological response (MPR) following neoadjuvant immunochemotherapy in NSCLC and to compare it against traditional radiological criteria.

Methods

A systematic search of PubMed, Embase, Cochrane Library, and Web of Science was conducted through October 26, 2025. Studies utilizing computed tomography (CT) or positron emission tomography/CT-based AI models to predict pCR or MPR were included. Methodological quality was appraised using the PROBAST (Prediction Model Risk of Bias Assessment Tool)+AI tool. Sensitivity, specificity, and area under the curve (AUC) were pooled using a bivariate random effects model.

Results

Twenty-three studies involving 2004 patients in validation sets were included, with histopathology as the gold standard. For pCR, AI models achieved a pooled sensitivity of 0.77 (95% CI 0.70‐0.83), specificity of 0.79 (95% CI 0.73‐0.84), and AUC of 0.85, significantly outperforming traditional criteria in sensitivity (0.77 vs 0.42; P

Subjects

MeSH terms (MEDLINE)

Carcinoma, Non-Small-Cell LungRadiomicsLung NeoplasmsNeoadjuvant TherapyArtificial IntelligenceImmunotherapyHumansPathologic Complete Response

Author keywords

NSCLCmeta-analysisneoadjuvant therapynon–small cell lung carcinomapathological responseradiomics

Authors and institutions

  • Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Science, No.1 Shuaifuyuan, Wangfujing, Beijing, Dongcheng District, 100730, China, 86 13621021237.
  • Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Cite

APA

Jiang, Z., Xu, Y., Jia, S., & Liu, H. (2026). Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis. Journal of Medical Internet Research, 28, e93892-e93892. https://doi.org/10.2196/93892

Vancouver

Jiang Z, Xu Y, Jia S, Liu H. Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis. Journal of Medical Internet Research. 2026;28:e93892-e93892. doi:10.2196/93892

BibTeX
@article{Jiang2026,
  author = {Jiang, Ziqi and Xu, Yuan and Jia, Shuyu and Liu, Hongsheng},
  title = {Radiomics-Based AI for Predicting Neoadjuvant Immunochemotherapy Pathological Response in Non–Small Cell Lung Cancer: Systematic Review and Meta-Analysis},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e93892--e93892},
  doi = {10.2196/93892}
}
Start for free →